3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Radiodermatitis
1
Papillomavirus Infections
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lung Neoplasms
1
Localized Prostate Carcinoma
1
Leukemia, Myeloid, Acute
1
Hepatitis B
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Endometrial Clear Cell Adenocarcinoma
1
Disease Progression
1
Interventions
Gemcitabine
4
pembrolizumab
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
Albumin-Bound Paclitaxel
2
4-fluorobenzoyl-TN-14003
2
regorafenib
1
olaparib
1
irinotecan sucrosofate
1
ibrutinib
1
adavosertib
1
Paclitaxel
1
PEGPH20
1
Oxaliplatin
1
Drug Therapy
1
Docetaxel
1
Cisplatin
1
Capecitabine
1
BKT140
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Metastatic Pancreatic Adenocarcinoma
×
Practice Guidelines as Topic
×
Clear all
No trials found.